Search for: "Teva USA" Results 641 - 660 of 716
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Aug 2024, 10:17 am by Dennis Crouch
Teva Pharmaceuticals USA, Inc., 586 U.S. 123 (2019), the Supreme Court held that a commercial sale to a third party may place the invention “on sale” under § 102(a)(1), even if the sale does not disclose the details of the invention to the public. [read post]
26 Sep 2022, 4:49 am by Dennis Crouch
Skinny Label Infringement in Teva Pharmaceuticals USA, Inc. v. [read post]
4 Aug 2015, 11:27 am by Lawrence B. Ebert
The bottom line :For the reasons that follow, we affirm in all respects.The background of this Hatch-Waxman case:After Allergan received FDA-approval of Lumigan 0.01%, Sandoz, Lupin,Hi-Tech, and Watson each submitted an Abbreviated NewDrug Application (“ANDA”) to the FDA, seeking approvalto engage in the commercial manufacture, use, importation,sale, or offer for sale of generic versions of Lumigan0.01% prior to the expiration of the ’504, ’353, ’118, ’605,and… [read post]
14 Jul 2021, 8:09 pm by Lawrence B. Ebert
The background of the opinion describes the rather complex set of issues: We describe the facts in the light most favorable to the party that won the jury verdict (here, the plaintiffs). [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
31 Mar 2010, 1:58 pm
Teva Pharm., USA, Inc., 429 F.3d 1364, 1377 (Fed. [read post]
16 Jan 2017, 5:44 pm by Dennis Crouch
Teva Pharmaceuticals USA, Inc., et al. [read post]
13 Dec 2018, 11:16 am by Adam Feldman
Teva Pharmaceuticals USA Inc., which asks: “Whether, under the Leahy-Smith America Invents Act, an inventor’s sale of an invention to a third party that is obligated to keep the invention confidential qualifies as prior art for purposes of determining the patentability of the invention. [read post]
23 Aug 2012, 12:47 pm by Bexis
Teva Pharmaceuticals USA, Inc., 2010 WL 8357563, slip op. at 1-2 (Tex. [read post]
21 May 2019, 6:18 am by Elizabeth McCuskey
They can be “subsumed within an already tightly circumscribed legal analysis,” as the court recently explained in the patent-construction context in Teva Pharmaceuticals USA Inc. v. [read post]